nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifabutin—CYP1A2—Betaxolol—glaucoma	0.108	0.247	CbGbCtD
Rifabutin—CYP3A4—Pilocarpine—glaucoma	0.0634	0.145	CbGbCtD
Rifabutin—CYP1A2—Clonidine—glaucoma	0.0591	0.135	CbGbCtD
Rifabutin—CYP3A4—Brinzolamide—glaucoma	0.0497	0.114	CbGbCtD
Rifabutin—CYP3A4—Dorzolamide—glaucoma	0.048	0.11	CbGbCtD
Rifabutin—CYP3A4—Methazolamide—glaucoma	0.0428	0.0982	CbGbCtD
Rifabutin—CYP3A4—Acetazolamide—glaucoma	0.0342	0.0785	CbGbCtD
Rifabutin—CYP3A4—Clonidine—glaucoma	0.031	0.071	CbGbCtD
Rifabutin—HSP90AA1—endothelium—glaucoma	0.0086	0.226	CbGeAlD
Rifabutin—HSP90B1—eye—glaucoma	0.00577	0.151	CbGeAlD
Rifabutin—HSP90B1—retina—glaucoma	0.00572	0.15	CbGeAlD
Rifabutin—HSP90B1—connective tissue—glaucoma	0.00556	0.146	CbGeAlD
Rifabutin—HSP90AA1—eye—glaucoma	0.00422	0.111	CbGeAlD
Rifabutin—HSP90AA1—retina—glaucoma	0.00418	0.11	CbGeAlD
Rifabutin—HSP90AA1—connective tissue—glaucoma	0.00407	0.107	CbGeAlD
Rifabutin—HSP90AA1—NRF2 pathway—TXN—glaucoma	0.00104	0.00516	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—C1QB—glaucoma	0.000996	0.00494	CbGpPWpGaD
Rifabutin—HSP90AA1—Validated targets of C-MYC transcriptional activation—CCND2—glaucoma	0.000988	0.0049	CbGpPWpGaD
Rifabutin—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.00097	0.00481	CbGpPWpGaD
Rifabutin—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000948	0.0047	CbGpPWpGaD
Rifabutin—CYP1A2—Estrogen Receptor Pathway—CYP1B1—glaucoma	0.000936	0.00464	CbGpPWpGaD
Rifabutin—HSP90AA1—NRF2 pathway—SLC6A1—glaucoma	0.000927	0.0046	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—TXN—glaucoma	0.000888	0.0044	CbGpPWpGaD
Rifabutin—HSP90AA1—Hypoxic and oxygen homeostasis regulation of HIF-1-alpha—TP53—glaucoma	0.000881	0.00437	CbGpPWpGaD
Rifabutin—HSP90AA1—Class I PI3K signaling events mediated by Akt—CDKN1B—glaucoma	0.00086	0.00427	CbGpPWpGaD
Rifabutin—HSP90AA1—EBV LMP1 signaling—TNF—glaucoma	0.000858	0.00425	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFR1 specific signals—VEGFA—glaucoma	0.000832	0.00412	CbGpPWpGaD
Rifabutin—HSP90AA1—Integrins in angiogenesis—FN1—glaucoma	0.000781	0.00387	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CTSA—glaucoma	0.000777	0.00385	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—CAV1—glaucoma	0.000772	0.00383	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—RPTOR—glaucoma	0.000762	0.00378	CbGpPWpGaD
Rifabutin—HSP90AA1—NRF2 pathway—TGFB2—glaucoma	0.000756	0.00375	CbGpPWpGaD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—NR3C1—glaucoma	0.000754	0.00374	CbGpPWpGaD
Rifabutin—HSP90AA1—EPHA-mediated growth cone collapse—VEGFA—glaucoma	0.000732	0.00363	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.00073	0.00362	CbGpPWpGaD
Rifabutin—CYP1A2—Estrogen metabolism—CYP1B1—glaucoma	0.000722	0.00358	CbGpPWpGaD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—MMP1—glaucoma	0.000693	0.00344	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.000691	0.00343	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000691	0.00343	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—TXNIP—glaucoma	0.000654	0.00324	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—TXN—glaucoma	0.000648	0.00321	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—TBK1—glaucoma	0.000641	0.00318	CbGpPWpGaD
Rifabutin—CYP1A2—Tamoxifen metabolism—CYP1B1—glaucoma	0.000638	0.00316	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—FGFR1OP—glaucoma	0.00063	0.00313	CbGpPWpGaD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—BCL2L1—glaucoma	0.000629	0.00312	CbGpPWpGaD
Rifabutin—Chest pain—Travoprost—glaucoma	0.000629	0.00194	CcSEcCtD
Rifabutin—Leukopenia—Pilocarpine—glaucoma	0.000627	0.00194	CcSEcCtD
Rifabutin—HSP90AA1—Axon guidance—NCK2—glaucoma	0.000626	0.00311	CbGpPWpGaD
Rifabutin—Nausea—Carteolol—glaucoma	0.000626	0.00193	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.000624	0.00193	CcSEcCtD
Rifabutin—Headache—Levobunolol—glaucoma	0.000624	0.00192	CcSEcCtD
Rifabutin—Shock—Brimonidine—glaucoma	0.000623	0.00192	CcSEcCtD
Rifabutin—Arthralgia—Brinzolamide—glaucoma	0.000621	0.00191	CcSEcCtD
Rifabutin—Chest pain—Brinzolamide—glaucoma	0.000621	0.00191	CcSEcCtD
Rifabutin—Myalgia—Brinzolamide—glaucoma	0.000621	0.00191	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000618	0.00191	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.000616	0.0019	CcSEcCtD
Rifabutin—Skin disorder—Brimonidine—glaucoma	0.000615	0.0019	CcSEcCtD
Rifabutin—Nausea—Diclofenamide—glaucoma	0.000615	0.0019	CcSEcCtD
Rifabutin—Pain—Bimatoprost—glaucoma	0.000612	0.00189	CcSEcCtD
Rifabutin—Confusional state—Dorzolamide—glaucoma	0.00061	0.00188	CcSEcCtD
Rifabutin—Feeling abnormal—Apraclonidine—glaucoma	0.000608	0.00188	CcSEcCtD
Rifabutin—Vomiting—Methazolamide—glaucoma	0.000606	0.00187	CcSEcCtD
Rifabutin—Gastrointestinal pain—Apraclonidine—glaucoma	0.000604	0.00186	CcSEcCtD
Rifabutin—Rash—Methazolamide—glaucoma	0.000601	0.00186	CcSEcCtD
Rifabutin—Dermatitis—Methazolamide—glaucoma	0.000601	0.00185	CcSEcCtD
Rifabutin—Eye disorder—Clonidine—glaucoma	0.000601	0.00185	CcSEcCtD
Rifabutin—Nausea—Carbachol—glaucoma	0.0006	0.00185	CcSEcCtD
Rifabutin—Headache—Methazolamide—glaucoma	0.000597	0.00184	CcSEcCtD
Rifabutin—Myalgia—Pilocarpine—glaucoma	0.000596	0.00184	CcSEcCtD
Rifabutin—Chest pain—Pilocarpine—glaucoma	0.000596	0.00184	CcSEcCtD
Rifabutin—Arthralgia—Pilocarpine—glaucoma	0.000596	0.00184	CcSEcCtD
Rifabutin—Shock—Dorzolamide—glaucoma	0.000595	0.00184	CcSEcCtD
Rifabutin—Paraesthesia—Acetazolamide—glaucoma	0.000593	0.00183	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—RAB8A—glaucoma	0.000593	0.00294	CbGpPWpGaD
Rifabutin—Nausea—Levobunolol—glaucoma	0.000591	0.00182	CcSEcCtD
Rifabutin—Skin disorder—Travoprost—glaucoma	0.000585	0.00181	CcSEcCtD
Rifabutin—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—glaucoma	0.000584	0.00289	CbGpPWpGaD
Rifabutin—Abdominal pain—Apraclonidine—glaucoma	0.000583	0.0018	CcSEcCtD
Rifabutin—Rash—Latanoprost—glaucoma	0.000582	0.0018	CcSEcCtD
Rifabutin—Agranulocytosis—Betaxolol—glaucoma	0.000582	0.00179	CcSEcCtD
Rifabutin—Dermatitis—Latanoprost—glaucoma	0.000582	0.00179	CcSEcCtD
Rifabutin—Dyspepsia—Acetazolamide—glaucoma	0.000581	0.00179	CcSEcCtD
Rifabutin—HSP90B1—Immune System—C1QB—glaucoma	0.00058	0.00288	CbGpPWpGaD
Rifabutin—Headache—Latanoprost—glaucoma	0.000578	0.00178	CcSEcCtD
Rifabutin—Skin disorder—Brinzolamide—glaucoma	0.000578	0.00178	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Brimonidine—glaucoma	0.000577	0.00178	CcSEcCtD
Rifabutin—Anorexia—Dorzolamide—glaucoma	0.000577	0.00178	CcSEcCtD
Rifabutin—CYP1A2—Estrogen metabolism—GSTM1—glaucoma	0.000577	0.00286	CbGpPWpGaD
Rifabutin—Confusional state—Pilocarpine—glaucoma	0.000577	0.00178	CcSEcCtD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.000575	0.00285	CbGpPWpGaD
Rifabutin—Decreased appetite—Acetazolamide—glaucoma	0.000574	0.00177	CcSEcCtD
Rifabutin—Insomnia—Brimonidine—glaucoma	0.000573	0.00177	CcSEcCtD
Rifabutin—HSP90B1—Metabolism of proteins—PAX6—glaucoma	0.000572	0.00284	CbGpPWpGaD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—BAD—glaucoma	0.00057	0.00283	CbGpPWpGaD
Rifabutin—Gastrointestinal disorder—Acetazolamide—glaucoma	0.00057	0.00176	CcSEcCtD
Rifabutin—Paraesthesia—Brimonidine—glaucoma	0.000569	0.00176	CcSEcCtD
Rifabutin—Nausea—Methazolamide—glaucoma	0.000566	0.00175	CcSEcCtD
Rifabutin—Dyspnoea—Brimonidine—glaucoma	0.000565	0.00174	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle—FGFR1OP—glaucoma	0.000564	0.0028	CbGpPWpGaD
Rifabutin—Shock—Pilocarpine—glaucoma	0.000563	0.00174	CcSEcCtD
Rifabutin—Bronchospasm—Timolol—glaucoma	0.000562	0.00173	CcSEcCtD
Rifabutin—Thrombocytopenia—Pilocarpine—glaucoma	0.00056	0.00173	CcSEcCtD
Rifabutin—Dyspepsia—Brimonidine—glaucoma	0.000558	0.00172	CcSEcCtD
Rifabutin—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000557	0.00276	CbGpPWpGaD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000554	0.00275	CbGpPWpGaD
Rifabutin—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000551	0.0017	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Travoprost—glaucoma	0.000549	0.00169	CcSEcCtD
Rifabutin—Insomnia—Dorzolamide—glaucoma	0.000547	0.00169	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Brimonidine—glaucoma	0.000547	0.00169	CcSEcCtD
Rifabutin—Anorexia—Pilocarpine—glaucoma	0.000545	0.00168	CcSEcCtD
Rifabutin—Feeling abnormal—Acetazolamide—glaucoma	0.000544	0.00168	CcSEcCtD
Rifabutin—Hypersensitivity—Apraclonidine—glaucoma	0.000544	0.00168	CcSEcCtD
Rifabutin—Paraesthesia—Dorzolamide—glaucoma	0.000543	0.00168	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000542	0.00167	CcSEcCtD
Rifabutin—Pain—Brimonidine—glaucoma	0.000542	0.00167	CcSEcCtD
Rifabutin—Dyspnoea—Dorzolamide—glaucoma	0.000539	0.00166	CcSEcCtD
Rifabutin—Insomnia—Brinzolamide—glaucoma	0.000538	0.00166	CcSEcCtD
Rifabutin—HSP90AA1—Integrins in angiogenesis—CDKN1B—glaucoma	0.000537	0.00267	CbGpPWpGaD
Rifabutin—Dyspnoea—Travoprost—glaucoma	0.000537	0.00166	CcSEcCtD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—CAV1—glaucoma	0.000537	0.00266	CbGpPWpGaD
Rifabutin—Paraesthesia—Brinzolamide—glaucoma	0.000534	0.00165	CcSEcCtD
Rifabutin—Dyspepsia—Dorzolamide—glaucoma	0.000533	0.00164	CcSEcCtD
Rifabutin—Dyspnoea—Brinzolamide—glaucoma	0.00053	0.00164	CcSEcCtD
Rifabutin—Dyspepsia—Travoprost—glaucoma	0.00053	0.00164	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle—RAB8A—glaucoma	0.00053	0.00263	CbGpPWpGaD
Rifabutin—Asthenia—Apraclonidine—glaucoma	0.00053	0.00163	CcSEcCtD
Rifabutin—Decreased appetite—Dorzolamide—glaucoma	0.000526	0.00162	CcSEcCtD
Rifabutin—Dyspepsia—Brinzolamide—glaucoma	0.000524	0.00162	CcSEcCtD
Rifabutin—Eye disorder—Betaxolol—glaucoma	0.000523	0.00161	CcSEcCtD
Rifabutin—Pruritus—Apraclonidine—glaucoma	0.000522	0.00161	CcSEcCtD
Rifabutin—Body temperature increased—Acetazolamide—glaucoma	0.000522	0.00161	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000521	0.00161	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Travoprost—glaucoma	0.00052	0.00161	CcSEcCtD
Rifabutin—Pain—Dorzolamide—glaucoma	0.000517	0.0016	CcSEcCtD
Rifabutin—Insomnia—Pilocarpine—glaucoma	0.000517	0.0016	CcSEcCtD
Rifabutin—Decreased appetite—Brinzolamide—glaucoma	0.000517	0.0016	CcSEcCtD
Rifabutin—HSP90B1—Immune System—TXN—glaucoma	0.000517	0.00256	CbGpPWpGaD
Rifabutin—Pain—Travoprost—glaucoma	0.000515	0.00159	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—OPTN—glaucoma	0.000514	0.00255	CbGpPWpGaD
Rifabutin—HSP90AA1—NRF2 pathway—GSTM1—glaucoma	0.000514	0.00255	CbGpPWpGaD
Rifabutin—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000514	0.00158	CcSEcCtD
Rifabutin—Paraesthesia—Pilocarpine—glaucoma	0.000513	0.00158	CcSEcCtD
Rifabutin—Asthenia—Bimatoprost—glaucoma	0.000513	0.00158	CcSEcCtD
Rifabutin—Dyspnoea—Pilocarpine—glaucoma	0.00051	0.00157	CcSEcCtD
Rifabutin—Pain—Brinzolamide—glaucoma	0.000509	0.00157	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by VEGF—CAV1—glaucoma	0.000507	0.00251	CbGpPWpGaD
Rifabutin—Pruritus—Bimatoprost—glaucoma	0.000506	0.00156	CcSEcCtD
Rifabutin—HSP90AA1—Regulation of Telomerase—CDKN1B—glaucoma	0.000506	0.00251	CbGpPWpGaD
Rifabutin—Immune system disorder—Betaxolol—glaucoma	0.000505	0.00156	CcSEcCtD
Rifabutin—Diarrhoea—Apraclonidine—glaucoma	0.000505	0.00156	CcSEcCtD
Rifabutin—Dyspepsia—Pilocarpine—glaucoma	0.000503	0.00155	CcSEcCtD
Rifabutin—Feeling abnormal—Dorzolamide—glaucoma	0.000499	0.00154	CcSEcCtD
Rifabutin—Decreased appetite—Pilocarpine—glaucoma	0.000497	0.00153	CcSEcCtD
Rifabutin—Feeling abnormal—Travoprost—glaucoma	0.000496	0.00153	CcSEcCtD
Rifabutin—HSP90AA1—Metabolism—NARFL—glaucoma	0.000496	0.00246	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CA5A—glaucoma	0.000496	0.00246	CbGpPWpGaD
Rifabutin—Gastrointestinal pain—Dorzolamide—glaucoma	0.000495	0.00153	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000494	0.00152	CcSEcCtD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	0.000493	0.00244	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—TNF—glaucoma	0.000493	0.00244	CbGpPWpGaD
Rifabutin—Gastrointestinal pain—Travoprost—glaucoma	0.000493	0.00152	CcSEcCtD
Rifabutin—CYP1A2—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000493	0.00244	CbGpPWpGaD
Rifabutin—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000492	0.00244	CbGpPWpGaD
Rifabutin—Feeling abnormal—Brinzolamide—glaucoma	0.00049	0.00151	CcSEcCtD
Rifabutin—Pain—Pilocarpine—glaucoma	0.000489	0.00151	CcSEcCtD
Rifabutin—HSP90AA1—EPH-Ephrin signaling—MMP2—glaucoma	0.000481	0.00238	CbGpPWpGaD
Rifabutin—Abdominal pain—Dorzolamide—glaucoma	0.000478	0.00148	CcSEcCtD
Rifabutin—Body temperature increased—Dorzolamide—glaucoma	0.000478	0.00148	CcSEcCtD
Rifabutin—Dysgeusia—Betaxolol—glaucoma	0.000477	0.00147	CcSEcCtD
Rifabutin—Chest pain—Clonidine—glaucoma	0.000476	0.00147	CcSEcCtD
Rifabutin—Arthralgia—Clonidine—glaucoma	0.000476	0.00147	CcSEcCtD
Rifabutin—Abdominal pain—Travoprost—glaucoma	0.000476	0.00147	CcSEcCtD
Rifabutin—Agranulocytosis—Timolol—glaucoma	0.000475	0.00147	CcSEcCtD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—TNF—glaucoma	0.000475	0.00236	CbGpPWpGaD
Rifabutin—Asthenia—Acetazolamide—glaucoma	0.000474	0.00146	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000473	0.00146	CcSEcCtD
Rifabutin—Feeling abnormal—Pilocarpine—glaucoma	0.000471	0.00145	CcSEcCtD
Rifabutin—Vomiting—Apraclonidine—glaucoma	0.000469	0.00145	CcSEcCtD
Rifabutin—Gastrointestinal pain—Pilocarpine—glaucoma	0.000468	0.00144	CcSEcCtD
Rifabutin—Hypersensitivity—Brimonidine—glaucoma	0.000467	0.00144	CcSEcCtD
Rifabutin—Dermatitis—Apraclonidine—glaucoma	0.000465	0.00143	CcSEcCtD
Rifabutin—Headache—Apraclonidine—glaucoma	0.000462	0.00143	CcSEcCtD
Rifabutin—Confusional state—Clonidine—glaucoma	0.00046	0.00142	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle—OPTN—glaucoma	0.00046	0.00228	CbGpPWpGaD
Rifabutin—HSP90AA1—LKB1 signaling events—TP53—glaucoma	0.000458	0.00227	CbGpPWpGaD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—NOS3—glaucoma	0.000458	0.00227	CbGpPWpGaD
Rifabutin—Asthenia—Brimonidine—glaucoma	0.000455	0.0014	CcSEcCtD
Rifabutin—Abdominal pain—Pilocarpine—glaucoma	0.000452	0.00139	CcSEcCtD
Rifabutin—Body temperature increased—Pilocarpine—glaucoma	0.000452	0.00139	CcSEcCtD
Rifabutin—Diarrhoea—Acetazolamide—glaucoma	0.000452	0.00139	CcSEcCtD
Rifabutin—Rash—Bimatoprost—glaucoma	0.000451	0.00139	CcSEcCtD
Rifabutin—Dermatitis—Bimatoprost—glaucoma	0.000451	0.00139	CcSEcCtD
Rifabutin—Anaemia—Betaxolol—glaucoma	0.00045	0.00139	CcSEcCtD
Rifabutin—Shock—Clonidine—glaucoma	0.000449	0.00139	CcSEcCtD
Rifabutin—Connective tissue disorder—Timolol—glaucoma	0.000449	0.00139	CcSEcCtD
Rifabutin—HSP90AA1—Disease—LRP12—glaucoma	0.000449	0.00223	CbGpPWpGaD
Rifabutin—Pruritus—Brimonidine—glaucoma	0.000448	0.00138	CcSEcCtD
Rifabutin—Headache—Bimatoprost—glaucoma	0.000448	0.00138	CcSEcCtD
Rifabutin—Thrombocytopenia—Clonidine—glaucoma	0.000447	0.00138	CcSEcCtD
Rifabutin—HSP90AA1—Integrins in angiogenesis—VEGFA—glaucoma	0.000447	0.00222	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—NCK2—glaucoma	0.000447	0.00222	CbGpPWpGaD
Rifabutin—Hypersensitivity—Dorzolamide—glaucoma	0.000446	0.00138	CcSEcCtD
Rifabutin—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000445	0.00221	CbGpPWpGaD
Rifabutin—Hypersensitivity—Travoprost—glaucoma	0.000444	0.00137	CcSEcCtD
Rifabutin—Skin disorder—Clonidine—glaucoma	0.000444	0.00137	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—TXNIP—glaucoma	0.000438	0.00217	CbGpPWpGaD
Rifabutin—Nausea—Apraclonidine—glaucoma	0.000438	0.00135	CcSEcCtD
Rifabutin—Hypersensitivity—Brinzolamide—glaucoma	0.000438	0.00135	CcSEcCtD
Rifabutin—Anorexia—Clonidine—glaucoma	0.000435	0.00134	CcSEcCtD
Rifabutin—Asthenia—Dorzolamide—glaucoma	0.000434	0.00134	CcSEcCtD
Rifabutin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000434	0.00215	CbGpPWpGaD
Rifabutin—Asthenia—Travoprost—glaucoma	0.000432	0.00133	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—TBK1—glaucoma	0.00043	0.00213	CbGpPWpGaD
Rifabutin—Pruritus—Dorzolamide—glaucoma	0.000428	0.00132	CcSEcCtD
Rifabutin—Eye disorder—Timolol—glaucoma	0.000427	0.00132	CcSEcCtD
Rifabutin—Asthenia—Brinzolamide—glaucoma	0.000427	0.00132	CcSEcCtD
Rifabutin—Pruritus—Travoprost—glaucoma	0.000426	0.00132	CcSEcCtD
Rifabutin—Nausea—Bimatoprost—glaucoma	0.000425	0.00131	CcSEcCtD
Rifabutin—Hypersensitivity—Pilocarpine—glaucoma	0.000421	0.0013	CcSEcCtD
Rifabutin—Pruritus—Brinzolamide—glaucoma	0.000421	0.0013	CcSEcCtD
Rifabutin—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—glaucoma	0.000421	0.00209	CbGpPWpGaD
Rifabutin—Vomiting—Acetazolamide—glaucoma	0.00042	0.0013	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Clonidine—glaucoma	0.000416	0.00128	CcSEcCtD
Rifabutin—HSP90AA1—Validated targets of C-MYC transcriptional activation—MMP9—glaucoma	0.000415	0.00206	CbGpPWpGaD
Rifabutin—Chest pain—Betaxolol—glaucoma	0.000415	0.00128	CcSEcCtD
Rifabutin—Myalgia—Betaxolol—glaucoma	0.000415	0.00128	CcSEcCtD
Rifabutin—Arthralgia—Betaxolol—glaucoma	0.000415	0.00128	CcSEcCtD
Rifabutin—Diarrhoea—Dorzolamide—glaucoma	0.000414	0.00128	CcSEcCtD
Rifabutin—Headache—Acetazolamide—glaucoma	0.000414	0.00128	CcSEcCtD
Rifabutin—Insomnia—Clonidine—glaucoma	0.000413	0.00127	CcSEcCtD
Rifabutin—Immune system disorder—Timolol—glaucoma	0.000413	0.00127	CcSEcCtD
Rifabutin—Diarrhoea—Travoprost—glaucoma	0.000412	0.00127	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000412	0.00127	CcSEcCtD
Rifabutin—Asthenia—Pilocarpine—glaucoma	0.00041	0.00127	CcSEcCtD
Rifabutin—Paraesthesia—Clonidine—glaucoma	0.00041	0.00127	CcSEcCtD
Rifabutin—Dyspnoea—Clonidine—glaucoma	0.000407	0.00126	CcSEcCtD
Rifabutin—Diarrhoea—Brinzolamide—glaucoma	0.000407	0.00126	CcSEcCtD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—NOS3—glaucoma	0.000406	0.00201	CbGpPWpGaD
Rifabutin—Pruritus—Pilocarpine—glaucoma	0.000405	0.00125	CcSEcCtD
Rifabutin—Confusional state—Betaxolol—glaucoma	0.000401	0.00124	CcSEcCtD
Rifabutin—Rash—Brimonidine—glaucoma	0.0004	0.00123	CcSEcCtD
Rifabutin—Dermatitis—Brimonidine—glaucoma	0.000399	0.00123	CcSEcCtD
Rifabutin—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	0.000398	0.00198	CbGpPWpGaD
Rifabutin—Headache—Brimonidine—glaucoma	0.000397	0.00122	CcSEcCtD
Rifabutin—Decreased appetite—Clonidine—glaucoma	0.000397	0.00122	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Clonidine—glaucoma	0.000394	0.00122	CcSEcCtD
Rifabutin—Nausea—Acetazolamide—glaucoma	0.000392	0.00121	CcSEcCtD
Rifabutin—Diarrhoea—Pilocarpine—glaucoma	0.000391	0.00121	CcSEcCtD
Rifabutin—Shock—Betaxolol—glaucoma	0.000391	0.00121	CcSEcCtD
Rifabutin—Pain—Clonidine—glaucoma	0.00039	0.0012	CcSEcCtD
Rifabutin—Dysgeusia—Timolol—glaucoma	0.00039	0.0012	CcSEcCtD
Rifabutin—Thrombocytopenia—Betaxolol—glaucoma	0.000389	0.0012	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—C1QB—glaucoma	0.000389	0.00193	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—C3—glaucoma	0.000387	0.00192	CbGpPWpGaD
Rifabutin—Skin disorder—Betaxolol—glaucoma	0.000386	0.00119	CcSEcCtD
Rifabutin—Vomiting—Dorzolamide—glaucoma	0.000385	0.00119	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by VEGF—NOS3—glaucoma	0.000383	0.0019	CbGpPWpGaD
Rifabutin—Rash—Dorzolamide—glaucoma	0.000382	0.00118	CcSEcCtD
Rifabutin—Dermatitis—Dorzolamide—glaucoma	0.000381	0.00118	CcSEcCtD
Rifabutin—Rash—Travoprost—glaucoma	0.00038	0.00117	CcSEcCtD
Rifabutin—Dermatitis—Travoprost—glaucoma	0.00038	0.00117	CcSEcCtD
Rifabutin—Headache—Dorzolamide—glaucoma	0.000379	0.00117	CcSEcCtD
Rifabutin—Anorexia—Betaxolol—glaucoma	0.000379	0.00117	CcSEcCtD
Rifabutin—Vomiting—Brinzolamide—glaucoma	0.000378	0.00117	CcSEcCtD
Rifabutin—Headache—Travoprost—glaucoma	0.000377	0.00116	CcSEcCtD
Rifabutin—Nausea—Brimonidine—glaucoma	0.000376	0.00116	CcSEcCtD
Rifabutin—Feeling abnormal—Clonidine—glaucoma	0.000376	0.00116	CcSEcCtD
Rifabutin—Rash—Brinzolamide—glaucoma	0.000375	0.00116	CcSEcCtD
Rifabutin—Dermatitis—Brinzolamide—glaucoma	0.000375	0.00116	CcSEcCtD
Rifabutin—Gastrointestinal pain—Clonidine—glaucoma	0.000373	0.00115	CcSEcCtD
Rifabutin—Headache—Brinzolamide—glaucoma	0.000373	0.00115	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—BCL2L1—glaucoma	0.000371	0.00184	CbGpPWpGaD
Rifabutin—Vomiting—Pilocarpine—glaucoma	0.000364	0.00112	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000362	0.00112	CcSEcCtD
Rifabutin—HSP90AA1—EPH-Ephrin signaling—MMP9—glaucoma	0.000361	0.00179	CbGpPWpGaD
Rifabutin—Body temperature increased—Clonidine—glaucoma	0.000361	0.00111	CcSEcCtD
Rifabutin—Abdominal pain—Clonidine—glaucoma	0.000361	0.00111	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—BAD—glaucoma	0.000361	0.00179	CbGpPWpGaD
Rifabutin—Rash—Pilocarpine—glaucoma	0.000361	0.00111	CcSEcCtD
Rifabutin—Dermatitis—Pilocarpine—glaucoma	0.00036	0.00111	CcSEcCtD
Rifabutin—Insomnia—Betaxolol—glaucoma	0.00036	0.00111	CcSEcCtD
Rifabutin—Nausea—Dorzolamide—glaucoma	0.000359	0.00111	CcSEcCtD
Rifabutin—Headache—Pilocarpine—glaucoma	0.000358	0.00111	CcSEcCtD
Rifabutin—Nausea—Travoprost—glaucoma	0.000358	0.0011	CcSEcCtD
Rifabutin—Paraesthesia—Betaxolol—glaucoma	0.000357	0.0011	CcSEcCtD
Rifabutin—HSP90AA1—Cellular responses to stress—SOD1—glaucoma	0.000357	0.00177	CbGpPWpGaD
Rifabutin—Dyspnoea—Betaxolol—glaucoma	0.000354	0.00109	CcSEcCtD
Rifabutin—Nausea—Brinzolamide—glaucoma	0.000353	0.00109	CcSEcCtD
Rifabutin—Dyspepsia—Betaxolol—glaucoma	0.00035	0.00108	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—TXN—glaucoma	0.000347	0.00172	CbGpPWpGaD
Rifabutin—Decreased appetite—Betaxolol—glaucoma	0.000346	0.00107	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Betaxolol—glaucoma	0.000343	0.00106	CcSEcCtD
Rifabutin—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	0.000341	0.00169	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000341	0.00169	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.000341	0.00169	CbGpPWpGaD
Rifabutin—Pain—Betaxolol—glaucoma	0.00034	0.00105	CcSEcCtD
Rifabutin—Nausea—Pilocarpine—glaucoma	0.00034	0.00105	CcSEcCtD
Rifabutin—Myalgia—Timolol—glaucoma	0.000339	0.00105	CcSEcCtD
Rifabutin—Chest pain—Timolol—glaucoma	0.000339	0.00105	CcSEcCtD
Rifabutin—Arthralgia—Timolol—glaucoma	0.000339	0.00105	CcSEcCtD
Rifabutin—HSP90AA1—Cellular responses to stress—CDKN2B—glaucoma	0.000337	0.00167	CbGpPWpGaD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000336	0.00104	CcSEcCtD
Rifabutin—Hypersensitivity—Clonidine—glaucoma	0.000336	0.00104	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—BAD—glaucoma	0.000336	0.00167	CbGpPWpGaD
Rifabutin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000335	0.00166	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—BAD—glaucoma	0.000332	0.00165	CbGpPWpGaD
Rifabutin—Asthenia—Clonidine—glaucoma	0.000328	0.00101	CcSEcCtD
Rifabutin—Feeling abnormal—Betaxolol—glaucoma	0.000328	0.00101	CcSEcCtD
Rifabutin—Confusional state—Timolol—glaucoma	0.000327	0.00101	CcSEcCtD
Rifabutin—HSP90B1—Metabolism of proteins—MMP1—glaucoma	0.000326	0.00162	CbGpPWpGaD
Rifabutin—HSP90AA1—EPH-Ephrin signaling—VEGFA—glaucoma	0.000325	0.00161	CbGpPWpGaD
Rifabutin—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	0.000324	0.00161	CbGpPWpGaD
Rifabutin—Pruritus—Clonidine—glaucoma	0.000323	0.000997	CcSEcCtD
Rifabutin—HSP90AA1—Cellular responses to stress—IL1A—glaucoma	0.000322	0.0016	CbGpPWpGaD
Rifabutin—Shock—Timolol—glaucoma	0.00032	0.000986	CcSEcCtD
Rifabutin—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000319	0.00158	CbGpPWpGaD
Rifabutin—Skin disorder—Timolol—glaucoma	0.000315	0.000973	CcSEcCtD
Rifabutin—HSP90AA1—Signaling Pathways—LRP12—glaucoma	0.000314	0.00156	CbGpPWpGaD
Rifabutin—Body temperature increased—Betaxolol—glaucoma	0.000314	0.00097	CcSEcCtD
Rifabutin—Diarrhoea—Clonidine—glaucoma	0.000312	0.000964	CcSEcCtD
Rifabutin—Anorexia—Timolol—glaucoma	0.00031	0.000955	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—CTSA—glaucoma	0.000303	0.0015	CbGpPWpGaD
Rifabutin—Musculoskeletal discomfort—Timolol—glaucoma	0.000296	0.000913	CcSEcCtD
Rifabutin—Insomnia—Timolol—glaucoma	0.000294	0.000906	CcSEcCtD
Rifabutin—Hypersensitivity—Betaxolol—glaucoma	0.000293	0.000904	CcSEcCtD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—VEGFA—glaucoma	0.000293	0.00145	CbGpPWpGaD
Rifabutin—Paraesthesia—Timolol—glaucoma	0.000292	0.0009	CcSEcCtD
Rifabutin—Vomiting—Clonidine—glaucoma	0.00029	0.000896	CcSEcCtD
Rifabutin—Dyspnoea—Timolol—glaucoma	0.00029	0.000893	CcSEcCtD
Rifabutin—HSP90AA1—Developmental Biology—PAX6—glaucoma	0.000289	0.00144	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—HEYL—glaucoma	0.000289	0.00143	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—FGFR1OP—glaucoma	0.000289	0.00143	CbGpPWpGaD
Rifabutin—Rash—Clonidine—glaucoma	0.000288	0.000888	CcSEcCtD
Rifabutin—Dermatitis—Clonidine—glaucoma	0.000288	0.000888	CcSEcCtD
Rifabutin—Headache—Clonidine—glaucoma	0.000286	0.000883	CcSEcCtD
Rifabutin—Dyspepsia—Timolol—glaucoma	0.000286	0.000882	CcSEcCtD
Rifabutin—Asthenia—Betaxolol—glaucoma	0.000285	0.00088	CcSEcCtD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—TNF—glaucoma	0.000283	0.0014	CbGpPWpGaD
Rifabutin—Decreased appetite—Timolol—glaucoma	0.000282	0.000871	CcSEcCtD
Rifabutin—HSP90AA1—Validated targets of C-MYC transcriptional activation—TP53—glaucoma	0.000282	0.0014	CbGpPWpGaD
Rifabutin—Pruritus—Betaxolol—glaucoma	0.000281	0.000868	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Timolol—glaucoma	0.00028	0.000865	CcSEcCtD
Rifabutin—Pain—Timolol—glaucoma	0.000278	0.000857	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by VEGF—VEGFA—glaucoma	0.000276	0.00137	CbGpPWpGaD
Rifabutin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000275	0.00137	CbGpPWpGaD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—TP53—glaucoma	0.000274	0.00136	CbGpPWpGaD
Rifabutin—Diarrhoea—Betaxolol—glaucoma	0.000272	0.000839	CcSEcCtD
Rifabutin—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000272	0.00135	CbGpPWpGaD
Rifabutin—Nausea—Clonidine—glaucoma	0.000271	0.000837	CcSEcCtD
Rifabutin—Feeling abnormal—Timolol—glaucoma	0.000268	0.000826	CcSEcCtD
Rifabutin—Gastrointestinal pain—Timolol—glaucoma	0.000266	0.000819	CcSEcCtD
Rifabutin—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000263	0.0013	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—IL1A—glaucoma	0.000257	0.00127	CbGpPWpGaD
Rifabutin—Body temperature increased—Timolol—glaucoma	0.000257	0.000792	CcSEcCtD
Rifabutin—Abdominal pain—Timolol—glaucoma	0.000257	0.000792	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—TXNIP—glaucoma	0.000255	0.00127	CbGpPWpGaD
Rifabutin—CYP1A2—Phase II conjugation—GSTT1—glaucoma	0.000254	0.00126	CbGpPWpGaD
Rifabutin—Vomiting—Betaxolol—glaucoma	0.000253	0.00078	CcSEcCtD
Rifabutin—HSP90B1—Metabolism of proteins—MMP2—glaucoma	0.000252	0.00125	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—CDKN1B—glaucoma	0.000251	0.00125	CbGpPWpGaD
Rifabutin—Rash—Betaxolol—glaucoma	0.000251	0.000773	CcSEcCtD
Rifabutin—Dermatitis—Betaxolol—glaucoma	0.00025	0.000773	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—TBK1—glaucoma	0.00025	0.00124	CbGpPWpGaD
Rifabutin—Headache—Betaxolol—glaucoma	0.000249	0.000768	CcSEcCtD
Rifabutin—HSP90AA1—Metabolism—CA1—glaucoma	0.000242	0.0012	CbGpPWpGaD
Rifabutin—Hypersensitivity—Timolol—glaucoma	0.000239	0.000738	CcSEcCtD
Rifabutin—Nausea—Betaxolol—glaucoma	0.000236	0.000729	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CCND2—glaucoma	0.000236	0.00117	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CTSA—glaucoma	0.000235	0.00116	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—CDKN1B—glaucoma	0.000234	0.00116	CbGpPWpGaD
Rifabutin—Asthenia—Timolol—glaucoma	0.000233	0.000719	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—CDKN1B—glaucoma	0.000231	0.00115	CbGpPWpGaD
Rifabutin—Pruritus—Timolol—glaucoma	0.00023	0.000709	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—C1QB—glaucoma	0.000226	0.00112	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—C3—glaucoma	0.000226	0.00112	CbGpPWpGaD
Rifabutin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000223	0.00111	CbGpPWpGaD
Rifabutin—Diarrhoea—Timolol—glaucoma	0.000222	0.000686	CcSEcCtD
Rifabutin—HSP90AA1—Metabolism—CA2—glaucoma	0.000222	0.0011	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—OPN4—glaucoma	0.000218	0.00108	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—BCL2L1—glaucoma	0.000216	0.00107	CbGpPWpGaD
Rifabutin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000213	0.00105	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CDKN2B—glaucoma	0.000212	0.00105	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—CCND2—glaucoma	0.000211	0.00105	CbGpPWpGaD
Rifabutin—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.00021	0.00104	CbGpPWpGaD
Rifabutin—Vomiting—Timolol—glaucoma	0.000206	0.000637	CcSEcCtD
Rifabutin—Rash—Timolol—glaucoma	0.000205	0.000632	CcSEcCtD
Rifabutin—Dermatitis—Timolol—glaucoma	0.000205	0.000631	CcSEcCtD
Rifabutin—Headache—Timolol—glaucoma	0.000203	0.000628	CcSEcCtD
Rifabutin—HSP90AA1—Signaling Pathways—HEYL—glaucoma	0.000203	0.001	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—TXN—glaucoma	0.000202	0.001	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PTGFR—glaucoma	0.000196	0.000973	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—BAD—glaucoma	0.000196	0.000971	CbGpPWpGaD
Rifabutin—Nausea—Timolol—glaucoma	0.000193	0.000595	CcSEcCtD
Rifabutin—HSP90AA1—Cellular responses to stress—CDKN2A—glaucoma	0.000193	0.000957	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—CDKN2B—glaucoma	0.000189	0.000938	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—HDAC9—glaucoma	0.00018	0.000895	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—MMP2—glaucoma	0.000179	0.000886	CbGpPWpGaD
Rifabutin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000172	0.000854	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—CDKN1B—glaucoma	0.000171	0.000847	CbGpPWpGaD
Rifabutin—CYP1A2—Phase II conjugation—GSTM1—glaucoma	0.000162	0.000804	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—TXN—glaucoma	0.000156	0.000774	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.000154	0.000761	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—RPTOR—glaucoma	0.000153	0.000761	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—C3—glaucoma	0.000151	0.00075	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—GSTT1—glaucoma	0.000149	0.000738	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NCK2—glaucoma	0.000149	0.000737	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000145	0.000721	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.000145	0.000721	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—BCL2L1—glaucoma	0.000145	0.000718	CbGpPWpGaD
Rifabutin—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	0.000144	0.000712	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—VEGFA—glaucoma	0.000142	0.000705	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CDKN1B—glaucoma	0.000136	0.000676	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—MMP9—glaucoma	0.000134	0.000666	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—BAD—glaucoma	0.000131	0.000651	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—MMP2—glaucoma	0.000128	0.000632	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HDAC9—glaucoma	0.000126	0.000627	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GSTT1—glaucoma	0.000121	0.0006	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CDKN2A—glaucoma	0.000121	0.0006	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.000121	0.0006	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—VEGFA—glaucoma	0.000121	0.000598	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—CYP1B1—glaucoma	0.000119	0.000588	CbGpPWpGaD
Rifabutin—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	0.000117	0.00058	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—GSTT1—glaucoma	0.000115	0.00057	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000111	0.000549	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—CDKN2A—glaucoma	0.000108	0.000536	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—TP53—glaucoma	0.000107	0.000532	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CDKN1B—glaucoma	0.000107	0.000531	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CA5A—glaucoma	0.000104	0.000517	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NARFL—glaucoma	0.000104	0.000517	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	0.000104	0.000514	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	0.000104	0.000514	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL1A—glaucoma	0.0001	0.000497	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SMO—glaucoma	9.89e-05	0.00049	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CDKN2B—glaucoma	9.7e-05	0.000481	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CYP1B1—glaucoma	9.64e-05	0.000478	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ABCA1—glaucoma	9.64e-05	0.000478	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—MMP9—glaucoma	9.58e-05	0.000475	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—CDKN1B—glaucoma	9.58e-05	0.000475	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—GSTM1—glaucoma	9.48e-05	0.00047	CbGpPWpGaD
Rifabutin—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	9.35e-05	0.000464	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—CYP1B1—glaucoma	9.15e-05	0.000454	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—CDKN1B—glaucoma	9.14e-05	0.000453	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NTRK2—glaucoma	9.05e-05	0.000449	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	9.03e-05	0.000448	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—C3—glaucoma	8.81e-05	0.000437	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—VEGFA—glaucoma	8.61e-05	0.000427	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—BCL2L1—glaucoma	8.43e-05	0.000418	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MTHFR—glaucoma	8.13e-05	0.000403	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CA5A—glaucoma	8.05e-05	0.000399	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NARFL—glaucoma	8.05e-05	0.000399	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NGFR—glaucoma	7.76e-05	0.000385	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GSTM1—glaucoma	7.71e-05	0.000382	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—BAD—glaucoma	7.64e-05	0.000379	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—APOE—glaucoma	7.57e-05	0.000376	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CAV1—glaucoma	7.5e-05	0.000372	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—TNF—glaucoma	7.38e-05	0.000366	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NTRK1—glaucoma	7.37e-05	0.000366	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—GSTM1—glaucoma	7.32e-05	0.000363	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	7.22e-05	0.000358	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—BAD—glaucoma	7.06e-05	0.00035	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—MTHFR—glaucoma	6.81e-05	0.000338	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CDKN2B—glaucoma	6.8e-05	0.000337	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EDN1—glaucoma	6.52e-05	0.000323	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—APOE—glaucoma	6.34e-05	0.000315	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CAV1—glaucoma	6.28e-05	0.000312	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—TP53—glaucoma	6.02e-05	0.000299	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NGF—glaucoma	5.99e-05	0.000297	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—C3—glaucoma	5.7e-05	0.000282	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—NOS3—glaucoma	5.67e-05	0.000281	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CDKN1B—glaucoma	5.32e-05	0.000264	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—APOE—glaucoma	5.3e-05	0.000263	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CAV1—glaucoma	5.25e-05	0.000261	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PTGS2—glaucoma	5.19e-05	0.000257	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CA1—glaucoma	5.09e-05	0.000253	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—FN1—glaucoma	5e-05	0.000248	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—BAD—glaucoma	4.94e-05	0.000245	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CTSA—glaucoma	4.93e-05	0.000245	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CDKN1B—glaucoma	4.91e-05	0.000244	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—NOS3—glaucoma	4.75e-05	0.000236	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CA2—glaucoma	4.66e-05	0.000231	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.55e-05	0.000226	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.55e-05	0.000226	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PTGS2—glaucoma	4.35e-05	0.000216	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NOS3—glaucoma	3.97e-05	0.000197	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CA1—glaucoma	3.93e-05	0.000195	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CTSA—glaucoma	3.81e-05	0.000189	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CA2—glaucoma	3.6e-05	0.000178	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CDKN1B—glaucoma	3.44e-05	0.000171	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—TXN—glaucoma	3.28e-05	0.000163	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MMP9—glaucoma	3.19e-05	0.000158	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	3e-05	0.000149	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.97e-05	0.000147	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—VEGFA—glaucoma	2.86e-05	0.000142	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTT1—glaucoma	2.55e-05	0.000126	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—TXN—glaucoma	2.53e-05	0.000126	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TP53—glaucoma	2.16e-05	0.000107	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.05e-05	0.000102	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ABCA1—glaucoma	2.03e-05	0.000101	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP1B1—glaucoma	2.03e-05	0.000101	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTT1—glaucoma	1.96e-05	9.74e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTM1—glaucoma	1.62e-05	8.04e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ABCA1—glaucoma	1.57e-05	7.76e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP1B1—glaucoma	1.57e-05	7.76e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—MTHFR—glaucoma	1.43e-05	7.11e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—APOE—glaucoma	1.33e-05	6.62e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CAV1—glaucoma	1.32e-05	6.55e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTM1—glaucoma	1.25e-05	6.21e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—MTHFR—glaucoma	1.11e-05	5.48e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—APOE—glaucoma	1.03e-05	5.11e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CAV1—glaucoma	1.02e-05	5.06e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NOS3—glaucoma	9.99e-06	4.96e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PTGS2—glaucoma	9.14e-06	4.53e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NOS3—glaucoma	7.71e-06	3.82e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PTGS2—glaucoma	7.05e-06	3.5e-05	CbGpPWpGaD
